1. Home
  2. SST vs POM Comparison

SST vs POM Comparison

Compare SST & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo System1 Inc.

SST

System1 Inc.

HOLD

Current Price

$2.70

Market Cap

12.9M

ML Signal

HOLD

POM

POMDOCTOR LIMITED American Depositary Shares

N/A

Current Price

$0.12

Market Cap

13.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
SST
POM
Founded
2013
2015
Country
United States
China
Employees
250
N/A
Industry
Diversified Commercial Services
Other Specialty Stores
Sector
Consumer Discretionary
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
12.9M
13.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SST
POM
Price
$2.70
$0.12
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
2.1M
18.1M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.06
52 Week High
$11.30
$6.43

Technical Indicators

Market Signals
Indicator
SST
POM
Relative Strength Index (RSI) 41.99 36.82
Support Level $2.01 $0.06
Resistance Level $4.84 $0.43
Average True Range (ATR) 0.52 0.09
MACD -0.17 -0.02
Stochastic Oscillator 1.94 10.43

Price Performance

Historical Comparison
SST
POM

About SST System1 Inc.

System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It operate several flagship brands across multiple consumer verticals, including shopping, travel and search, and a customer acquisition and marketing platform powered by Artificial Intelligence and machine learning. The company's segment includes Marketing and Products. It generates maximum revenue from the Marketing segment. Geographically, it operates in United States and Other countries.

About POM POMDOCTOR LIMITED American Depositary Shares

Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.

Share on Social Networks: